My Profile
Matthew Goldstein
Raising intellectual capital on Wall Street
See all posts
Thu 26 Nov 2009 | 12:47 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Allos Therapeutics Inc
Allos Therapeutics Inc (ALTH.O) (Consolidated Issue listed on NASDAQ Global Market)
sector:
Healthcare
.
industry:
Biotechnology
ยท
View
ALTH
on other exchanges
As of 25 Nov 2009
6.65
USD
Price Change
+0.30
Percent Change
+4.72%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Age
Since
Current Position
Bennett, Bruce
58
2008
Vice President - Pharmaceutical Operations
Graboyes, Marc
39
2008
Senior Vice President, General Counsel, Secretary
Clark, David
40
2007
Principal Financial Officer, Vice President - Finance, Treasurer, Assistant Secretary
Berns, Paul
42
2006
President, Chief Executive Officer, Director
Caruso, James
50
2006
Executive Vice President, Chief Commercial Officer
Casey, Michael
63
2002
Director
Hen, Stewart
42
2005
Director
Leff, Jonathan
40
2005
Director
Lynch, Timothy
39
2005
Director
Latts, Jeffrey
61
2007
Director
Stout, David
55
2009
Director
Hoffman, Stephen
55
2001
Chairman of the Board
Find out more about ALTH.O
Insider Trading